Darbepoetin-alfa: improved efficacy against chemotherapy-induced anaemia?

Author：

ISSN： 1173-8324

Source： Inpharma, Vol.1, Iss.1350, 2002-01, pp. : 9-10

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

The use of darbepoetin alfa for the treatment of chemotherapy-induced anaemia

By Vansteenkiste Johan Wauters Isabelle

Expert Opinion on Pharmacotherapy, Vol. 6, Iss. 3, 2005-03 ,pp. : 429-440

Informa Healthcare

Access to resources Recommend Favorite

Economic Evaluation of Weekly Epoetin Alfa versus Biweekly Darbepoetin Alfa for Chemotherapy-Induced Anaemia: Evidence from a 16-Week Randomised Trial

By Reed Shelby D. Radeva Jasmina I.

PharmacoEconomics, Vol. 24, Iss. 5, 2006-01 ,pp. : 479-494

Adis International

Access to resources Recommend Favorite

Epoetin alfa cost effective in chemotherapy-induced anaemia

PharmacoEconomics and Outcomes News, Vol. 1, Iss. 493, 2005-01 ,pp. : 15-15

Adis International

Access to resources Recommend Favorite

Epoetin alfa cost effective in chemotherapy-induced anaemia

Inpharma, Vol. 1, Iss. 1518, 2005-01 ,pp. : 6-6

Adis International

Access to resources Recommend Favorite

Darbepoetin Alfa: In Patients with Chemotherapy-Related Anaemia

By Cvetkovic R.S. Goa K.L.

Drugs, Vol. 63, Iss. 11, 2003-01 ,pp. : 1067-1074

Adis International

Access to resources Recommend Favorite